We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $23.2M
1-Year Est. Return 88.58%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+88.58%
3 Year Est. Return
+303.94%
5 Year Est. Return
+476.72%
10 Year Est. Return
+633.34%
AUM
$23.2M
AUM Growth
-$146M
Cap. Flow
-$152M
Cap. Flow %
-655.29%
Top 10 Hldgs %
84.35%
Holding
52
New
4
Increased
14
Reduced
9
Closed
24

Top Buys

Rank Stock Value
1
XP icon
XP
XP
+$183K
2
LLY icon
Eli Lilly
LLY
+$13.2K
3
ABT icon
Abbott
ABT
+$4.07K
4
ISRG icon
Intuitive Surgical
ISRG
+$3.54K
5
ABBV icon
AbbVie
ABBV
+$3.33K

Sector Composition

Rank Sector Weight
1 Financials 35.97%
2 Technology 32.54%
3 Healthcare 27.68%
4 Communication Services 0.06%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNE icon
1
StoneCo
STNE
$2.71B
$6.71M 28.98%
475,123
-2,178,044
-82% -$33.5M
XP icon
2
XP
XP
$8.61B
$4.94M 21.35%
259,548
+9,484
+4% +$183K
NU icon
3
Nu Holdings
NU
$65.6B
$3.39M 14.62%
235,574
-56,568
-19% -$917K
LLY icon
4
Eli Lilly
LLY
$1.05T
$1.13M 4.89%
1,231
+13
+1% +$13.2K
SOLS
5
PUT
Solstice Advanced Materials
SOLS
$9.27B
$760K 3.28%
+2,000
New +$137K
ABBV icon
6
AbbVie
ABBV
$450B
$668K 2.89%
3,071
+15
+0.5% +$3.33K
INCY icon
7
Incyte
INCY
$23.4B
$529K 2.28%
5,620
-3,470
-38% -$346K
JNJ icon
8
Johnson & Johnson
JNJ
$609B
$521K 2.25%
2,132
+9
+0.4% +$2.1K
ONC
9
BeOne Medicines Ltd
ONC
$32.4B
$508K 2.19%
1,711
-848
-33% -$274K
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$374K 1.61%
6,161
+26
+0.4% +$1.52K
TSM icon
11
TSMC
TSM
$2.07T
$351K 1.52%
1,038
-466
-31% -$160K
TMO icon
12
Thermo Fisher Scientific
TMO
$198B
$346K 1.49%
704
+6
+0.9% +$3.26K
ISRG icon
13
Intuitive Surgical
ISRG
$122B
$346K 1.49%
750
+7
+0.9% +$3.54K
GILD icon
14
Gilead Sciences
GILD
$167B
$325K 1.4%
2,331
+9
+0.4% +$1.26K
ABT icon
15
Abbott
ABT
$175B
$318K 1.37%
3,094
+36
+1% +$4.07K
NVDA icon
16
NVIDIA
NVDA
$4.91T
$265K 1.14%
1,519
-883
-37% -$162K
MCK icon
17
McKesson
MCK
$98.5B
$246K 1.06%
284
+2
+0.7% +$1.78K
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$123B
$240K 1.04%
537
+5
+0.9% +$2.33K
MDGL icon
19
Madrigal Pharmaceuticals
MDGL
$12.8B
$227K 0.98%
433
-192
-31% -$91.7K
ZTS icon
20
Zoetis
ZTS
$32.1B
$212K 0.92%
1,796
+9
+0.5% +$1.11K
INSM icon
21
Insmed
INSM
$23.5B
$212K 0.92%
1,296
-1,203
-48% -$185K
VNET
22
VNET Group
VNET
$2.1B
$208K 0.9%
24,794
-25,288
-50% -$268K
BSX icon
23
Boston Scientific
BSX
$65.4B
$205K 0.89%
3,273
+26
+0.8% +$2.08K
STNE icon
24
CALL
StoneCo
STNE
$2.71B
$45K 0.19%
570
+44
+8% +$676
EEM icon
25
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
$30.8K 0.13%
+3,055
New +$180K

Similar funds

JGP Global Gestao de Recursos's Q1 2026 Portfolio in Review

As of Q1 2026, JGP Global Gestao de Recursos held 52 positions worth $23.2M, down 86% from $169M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $152M in Q1 2026, closing 24 positions and reducing 9 holdings. Its most notable exit was New Gold Inc, an estimated $80M position sold in full.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 6.3% a quarter earlier, followed by Technology and Healthcare.

Against the trend, JGP Global Gestao de Recursos added an estimated $183K to XP.

  • JGP Global Gestao de Recursos added most to XP in Q1 2026, an estimated $183K increase.
  • JGP Global Gestao de Recursos's biggest Q1 2026 reduction was StoneCo, cutting an estimated $33.5M.
  • JGP Global Gestao de Recursos fully exited New Gold Inc in Q1 2026, selling an estimated $80M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 84% of its $23.2M portfolio in Q1 2026.
  • JGP Global Gestao de Recursos opened 4 new positions and closed 24 in Q1 2026.
  • JGP Global Gestao de Recursos's portfolio value fell 86% quarter-over-quarter to $23.2M.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2026, filed 8 May 2026.